Adherence to K/DOQI guidelines for bone metabolism & disease in chronic kidney disease.

被引：0
|
作者：
Hoy, Tracey
Fisher, Maxine
Borker, Rohit
Barber, Beth
Stolshek, Brad
Goodman, William
机构：
[1] HealthCore Inc, Wilmington, DE USA
[2] Amgen Inc, Thousand Oaks, CA USA
来源：
AMERICAN JOURNAL OF KIDNEY DISEASES | 2007年 / 49卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
85
引用
收藏
页码：A46 / A46
页数：1
相关论文
共 50 条
  • [31] ADHERENCE TO THE NATIONAL KIDNEY FOUNDATION OUTCOMES QUALITY INITIATIVE GUIDELINES (K/DOQI) WITH RESPECT TO PTH AND VITAMIN D SCREENING IN CHRONIC KIDNEY DISEASE STAGE 3 PATIENTS
    Law, J. H.
    Kantor, Y.
    Kumari, M.
    Schlanger, L.
    Tangpricha, V.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2009, 57 (01) : 398 - 399
  • [32] NKF issues new K/DOQI guideline on bone disease and metabolism in CKD
    不详
    DIALYSIS & TRANSPLANTATION, 2003, 32 (11) : 644 - +
  • [33] Refinements of K/DOQI chronic kidney disease staging for practical implemention.
    Rutkowski, MP
    Mann, WL
    Araki, DS
    Wong, GH
    Derose, SF
    Ledezma, ML
    Mihara, NK
    Yeoh, HH
    Crooks, PW
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 676A - 677A
  • [34] K-DOQI guidelines for calcium and phosphorus metabolism in cronic kidney disease: outcomes, compliance and new drugs for treatment
    Negri, A. L.
    NEFROLOGIA, 2007, 27 (06): : 670 - +
  • [35] Phosphate binder therapy for attainment of K/DOQI™ bone metabolism guidelines
    Nolan, CR
    KIDNEY INTERNATIONAL, 2005, 68 : S7 - S14
  • [36] Difficulties in achieving the K/DOQI practice guidelines for bone and mineral metabolism
    González, EA
    Al-Aly, Z
    Martin, KJ
    SEMINARS IN DIALYSIS, 2005, 18 (03) : 171 - 174
  • [37] Relevance of chronic kidney disease classification (K/DOQI) in renal transplant patients
    Fernandez-Fresnedo, G.
    de Francisco, A.
    Ruiz, J. C.
    Cotorruelo, J. G.
    Alamillo, C. G.
    Valero, R.
    Castaneda, O.
    Zalduendo, B.
    Izquierdo, M. J.
    Arias, M.
    TRANSPLANTATION PROCEEDINGS, 2006, 38 (08) : 2402 - 2403
  • [38] Response to the Comment 'Are the aims of the K/DOQI guidelines for mineral metabolism disorders in patients with stage 3-5 chronic kidney disease unachievable or inadequate?'
    Fernandez-Giraldez, Elvira
    NEFROLOGIA, 2013, 33 (03): : 424 - 425
  • [39] Bone metabolism in chronic kidney disease in childhood
    Haffner, D.
    Querfeld, U.
    MONATSSCHRIFT KINDERHEILKUNDE, 2013, 161 (11) : 1011 - +
  • [40] The role of sevelamer in achieving the kidney disease outcomes quality initiative (K/DOQI) guidelines for hyperphosphatemia
    Pai, AB
    Smeeding, JE
    Brook, RA
    CURRENT MEDICAL RESEARCH AND OPINION, 2004, 20 (07) : 991 - 999
12345